Ketamine in Borderline Personality Disorder

NCT03395314 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped assessment of project in wake of covid-19 related interruptions

Conditions

Borderline Personality Disorder

Interventions

DRUG: Ketamine
DRUG: Midazolam

Sponsor

Yale University

Collaborators

[object Object]
[object Object]